Top news from MedWatch this week

Miss anything?

Photo: MedWatch


Dupixent might halt ”the atopic march,” research finds

Ferring moves into new Danish headquarters

Ambu’s endoscope business would have worked out without Invendo acquisition, CEO says

Ambu wants to tighten focus under renewed strategy

Enochian believes in victory in former CFO’s wrongful termination lawsuit


Pfizer denies texting missteps in negotiating Covid-19 contracts with EU

Novo Nordisk targets combined launch of insulin app and once-weekly insulin

Film star’s foundation grants Muna Therapeutics USD 4.9m

EU Commission accuses Teva of breaking antitrust laws


Older diabetes drugs linked to reduced dementia risk in study

Ambu begins production in new Mexico plant

GN Hearing has launched new product platform in some European countries

Sonova remains unconvinced about OTC viability

Sonova is testing new model for raising listing prices


Sony and WSA launch their first OTC hearing aids

GN Hearing CEO: Worldwide hearing market is steady or slightly declining

GSK boasts 83% efficacy for RSV vaccine candidate

Demant takes the temperature of the hearing aid market

GN Hearing is ready to launch OTC hybrid hearing device

FGN Hearing is ready to launch OTC hybrid hearing deviceriday

CHMP recommends approval of 10 drugs at October meeting

WSA CEO: Consumers are taking longer to decide – but there is no crisis

GN Hearing has an OTC head start, CEO says

Read MedWatch’s coverage of the EUHA conference

GN Hearing ”satisfied” with brand presence at Costco, sees benefits of rumored new supplier opening

GN Hearing CEO: Confidence is affected when you don’t perform as expected

More from MedWatch

Further reading

Latest news

See all jobs